Mylan EPD in Canada - a subsidiary of one of the world's leading pharmaceutical companies, Mylan N.V. announced the launch of MyFreshStart for patients taking Mavik, an innovative, digital medication adherence and engagement programme for patients who have been prescribed Mavik (trandolapril) in Canada.

The MyFreshStart programme, offered to patients through participating pharmacies, provides tools to help increase compliant behaviors such as maintaining prescription refills and taking Mavik as prescribed.

Head of Mylan EPD in Canada Barry Hayter commented: "We're excited to announce the launch of MyFreshStart for pharmacists and their patients. We know that nonadherence negatively impacts health outcomes, and we believe this programme provides pharmacists with a meaningful platform to discuss the importance of compliance with their patients. This new resource reinforces Mylan's commitment to expand access to high quality medicine as we innovate to meet unmet needs."

Developed with support from US-based HealthPrize Technologies, LLC, MyFreshStart seeks to educate patients about hypertension (high blood pressure) and how they can better manage it through engaging activities such as quizzes, daily fortunes, leaderboards and sweepstakes. Once enrolled in MyFreshStart through a participating pharmacy, patients can access the platform to begin earning points that can be redeemed for health-related items.

Mylan EPD is offering MyFreshStart at no cost to pharmacies, which serve as the primary provider of patient enrollment for the program, and looks forward to continue partnering with pharmacists as key drivers of patient engagement and empowerment.